2025
Distal Radius Fracture in the Setting of Human Immunodeficiency Virus: Management and Adverse Events
Hosseini H, Kammien A, Bach K, Allam O, Grauer J, Colen D. Distal Radius Fracture in the Setting of Human Immunodeficiency Virus: Management and Adverse Events. The Journal Of Hand Surgery 2025, 50: 451-458. PMID: 39895439, DOI: 10.1016/j.jhsa.2024.12.017.Peer-Reviewed Original ResearchHuman immunodeficiency virusDistal radius fracturesHuman immunodeficiency virus statusAntiretroviral therapyAdverse eventsRadius fracturesTreatment modalitiesOpen treatmentImmunodeficiency virusClosed treatmentHIV-negative patientsHIV-negative cohortAssociated with treatment modalityYear of fractureAntiretroviral therapy statusManagement of distal radius fracturesElevated fracture riskRate of malunionAssociated with greater incidenceModifiable risk factorsNational administrative databaseExperience adverse eventsChi-square testPrognostic IIFracture risk
2023
Risk of death and readmission among individuals with heart failure and HIV: A systematic review and meta-analysis
Zhou Y, Zhang X, Gao Y, Alvi R, Erqou S, Chen Y, Wang H, Wang W, Li X, Zanni M, Neilan T, Vermund S, Qian H, Qian F. Risk of death and readmission among individuals with heart failure and HIV: A systematic review and meta-analysis. Journal Of Infection And Public Health 2023, 17: 70-75. PMID: 37992436, DOI: 10.1016/j.jiph.2023.11.004.Peer-Reviewed Original ResearchConceptsHeart failureHF patientsRisk of HFHuman immunodeficiency virus statusPoor HF outcomesRisk of deathWeb of ScienceCause deathCause readmissionHF outcomesAdult patientsCohort studyHIV infectionHIV statusCochrane LibraryIndependent associationVirus statusHigh riskDeath outcomesHIVReadmissionPatientsSystematic reviewSystematic searchRiskComparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta‐analysis
Shin H, Shin H, Rahmati M, Koyanagi A, Jacob L, Smith L, Rhee S, Kwon R, Kim M, Kim S, Shin J, Min C, Cho W, Yon D. Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta‐analysis. Journal Of Medical Virology 2023, 95: e28713. PMID: 36991570, DOI: 10.1002/jmv.28713.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusOdds ratioMeta-analysisClinical manifestationsSystematic reviewHuman immunodeficiency virus statusComparison of clinical manifestationsConfidence intervalsComparison to patientsInfection of syphilisSite of infectionRandom-effects modelImmunodeficiency virusSkin rashClinical featuresIncreased riskMucosal contactPooled prevalencePatientsSevere symptomsPLWHHistorical infectionOddsGoogle ScholarMPOXHuman Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout
Lea A, Leyden W, Sofrygin O, Marafino B, Skarbinski J, Napravnik S, Agil D, Augenbraun M, Benning L, Horberg M, Jefferson C, Marconi V, Park L, Gordon K, Bastarache L, Gangireddy S, Althoff K, Coburn S, Gebo K, Lang R, Williams C, Silverberg M. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout. Clinical Infectious Diseases 2023, 76: 1727-1734. PMID: 36861341, PMCID: PMC10209434, DOI: 10.1093/cid/ciad084.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusAdjusted risk ratioCOVID-19 hospitalizationMechanical ventilationTenofovir useHIV statusAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSevere coronavirus disease 2019 (COVID-19) outcomesSyndrome coronavirus 2 infectionCoronavirus disease 2019 (COVID-19) outcomesHuman immunodeficiency virus statusCohort of PWHCD4 cell countCharlson Comorbidity IndexCoronavirus 2 infectionHIV RNA levelsUnited States cohortBody mass indexCOVID-19 severityCOVID-19 vaccine availabilityReal-world analysisTenofovir exposureComorbidity indexMass indexReceipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)
Shahrir S, Crothers K, McGinnis K, Chan K, Baeten J, Wilson S, Butt A, Pisani M, Baldassarri S, Justice A, Williams E. Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018). Open Forum Infectious Diseases 2023, 10: ofad089. PMID: 36968969, PMCID: PMC10034589, DOI: 10.1093/ofid/ofad089.Peer-Reviewed Original ResearchVeterans Aging Cohort StudyAging Cohort StudyHuman immunodeficiency virusCessation medicationsCohort studyCurrent smokersCurrent smokingHIV statusImmunodeficiency virusRelative riskHuman immunodeficiency virus statusSmoking cessation medicationsNicotine replacement therapyRates of receiptDangers of smokingOutpatient prescriptionsReplacement therapyPharmacy dataVirus statusTobacco useAnnual rateMedicationsSmokingPWHStatistical difference
2022
Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency Virus
Toribio M, Wilks M, Hedgire S, Lu M, Cetlin M, Wang M, Alhallak I, Durbin C, White K, Wallis Z, Schnittman S, Stanley T, El-Fakhri G, Lee H, Autissier P, Zanni M, Williams K, Grinspoon S. Increased Macrophage-Specific Arterial Infiltration Relates to Noncalcified Plaque and Systemic Immune Activation in People With Human Immunodeficiency Virus. The Journal Of Infectious Diseases 2022, 226: 1823-1833. PMID: 35856671, PMCID: PMC10205602, DOI: 10.1093/infdis/jiac301.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusAtherosclerotic cardiovascular diseaseAortic plaque volumeSystemic immune activationArterial infiltrationImmune activationImmunodeficiency virusPlaque volumeHistory of clinical ASCVDCD4+/CD8+ T-cell ratioHuman immunodeficiency virus statusCD8+ T cellsMarkers of immune activationClinical atherosclerotic cardiovascular diseasePersistent immune activationT cell ratioAtherosclerotic cardiovascular disease riskT cellsImmune phenotypeNoncalcified plaqueSystemic markersASCVD riskPWHCardiovascular diseaseUptake volume
2021
Prostate Cancer Screening and Incidence among Aging Persons Living with HIV
Leapman MS, Stone K, Wadia R, Park LS, Gibert CL, Goetz MB, Bedimo R, Rodriguez-Barradas M, Shebl F, Justice AC, Brown ST, Crothers K, Sigel KM. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV. Journal Of Urology 2021, 207: 324-332. PMID: 34555924, PMCID: PMC8741750, DOI: 10.1097/ju.0000000000002249.Peer-Reviewed Original ResearchConceptsPSA testingHIV statusProstate cancerProstate biopsyCancer incidenceHuman immunodeficiency virus statusProstate-specific antigen (PSA) testingVeterans Aging Cohort StudyProspective national cohortMultivariable Poisson modelsAging Cohort StudySpecific antigen testingHuman immunodeficiency virusProstate cancer screeningUninfected comparatorsCohort studyIncident cancerAntigen testingImmunodeficiency virusMean ageCancer screeningNational cohortCancer stageVirus statusMultivariable model
2017
Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men
Qian HZ, Hu Y, Carlucci JG, Yin L, Li X, Giuliano AR, Li D, Gao L, Shao Y, Vermund SH. Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men. Sexually Transmitted Diseases 2017, 44: 656-662. PMID: 28876311, PMCID: PMC5719885, DOI: 10.1097/olq.0000000000000672.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus statusAnal HPVHuman papillomavirus infectionOncogenic HPV typesGenital HPVHIV seropositivityPapillomavirus infectionHPV typesVirus statusAnal siteAnatomic sitesAnal sexAnal human papillomavirus (HPV) infectionInsertive anal sexReceptive anal sexCross-sectional studyInconsistent condom useUninfected MSMHPV genotypingMiddle-income countriesHIV serostatusHuman papillomavirusChinese MSMHPVChinese menHuman papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa
Dylla L, Abar B, Williamson A, Meiring T, Bekker L, Adler D. Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa. Journal Of AIDS And HIV Research 2017, 9: 202-206. PMID: 29707404, PMCID: PMC5920558, DOI: 10.5897/jahr2017.0445.Peer-Reviewed Original ResearchHuman immunodeficiency virusHuman papillomavirusHPV genotypesHPV infectionHPV-18Human immunodeficiency virus co-infectionLow-risk HPV genotypesHuman immunodeficiency virus statusHigh-risk human papillomavirusAlpha 7Co-InfectionConcurrent HPV infectionsHIV-uninfected counterpartsHPV co-infectionRisk HPV genotypesHR-HPV infectionHuman papillomavirus genotypesHuman papillomavirus screeningInvasive cervical cancerHIV-infected adolescentsMultiple concurrent infectionsHR-HPVHIV infectionImmunodeficiency virusRate of infectionHigh Prevalence of Treponema pallidum Infection in Brazilian Prisoners.
Correa ME, Croda J, Coimbra Motta de Castro AR, Maria do Valle Leone de Oliveira S, Pompilio MA, Omizolo de Souza R, Ferreira de Sá Queiroz JH, Esther da Silva K, Ko AI, Simionatto S. High Prevalence of Treponema pallidum Infection in Brazilian Prisoners. American Journal Of Tropical Medicine And Hygiene 2017, 97: 1078-1084. PMID: 28820706, PMCID: PMC5637599, DOI: 10.4269/ajtmh.17-0098.Peer-Reviewed Original ResearchConceptsActive syphilisSyphilis prevalenceHigh prevalenceBrazilian prisonersHuman immunodeficiency virus statusGenital ulcer diseaseIntravenous drug usersHigh-risk groupUnprotected sexual practicesMultivariable regression analysisCross-sectional studyActive syphilis prevalenceNew syphilis casesPopulation-based sampleDevelopment of syphilisCongenital infectionUlcer diseaseSyphilis testingRisk factorsVirus statusScreening programSerological statusSyphilis casesSevere formDrug users
2012
Isoniazid preventive therapy in correctional facilities: a systematic review [Review article]
Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in correctional facilities: a systematic review [Review article]. The International Journal Of Tuberculosis And Lung Disease 2012, 16: 871-879. PMID: 22410101, DOI: 10.5588/ijtld.11.0447.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyIPT initiationPreventive therapySystematic reviewHuman immunodeficiency virus statusCompletion ratesPrevalent adverse reactionsCorrectional facilitiesIPT effectivenessTreatment interruptionActive tuberculosisViral hepatitisMiddle-income countriesTB controlAdverse reactionsRisk factorsVirus statusEligible studiesCommunity settingsTuberculosisLow-income countriesMajor causeJail settingsAdverse effectsInternational recommendations
2011
Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff
Kanjee Z, Catterick K, Moll AP, Amico KR, Friedland GH. Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff. Journal Of Hospital Infection 2011, 79: 333-338. PMID: 21978608, DOI: 10.1016/j.jhin.2011.06.017.Peer-Reviewed Original ResearchConceptsMDR-TB/XDRHuman immunodeficiency virus statusRural South African hospitalNosocomial TB transmissionStigma of TBTuberculosis infection controlTB/HIVDrug-resistant TBInfection control knowledgeHealth informationSouth African hospitalsSurvey of knowledgeBehavioral change interventionsTB-ICTB infectionXDR-TBTB deathsTB transmissionVirus statusHealthcare workersAfrican hospitalsInfection controlHospital staffRural South AfricaBaseline assessment
1996
Antibodies to Bartonella Species in Inner-city Intravenous Drug Users in Baltimore, Md
Comer J, Flynn C, Regnery R, Vlahov D, Childs J. Antibodies to Bartonella Species in Inner-city Intravenous Drug Users in Baltimore, Md. JAMA Internal Medicine 1996, 156: 2491-2495. PMID: 8944742, DOI: 10.1001/archinte.1996.00440200111014.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus statusB quintanaRisk factorsDrug usersB henselaeDrug useVirus statusHuman immunodeficiency virus-seropositive individualsHuman immunodeficiency virus (HIV) infectionSerum samplesImmunodeficiency virus infectionAvailable serum samplesSignificant risk factorsBehavioral risk factorsPossible risk factorsSignificant inverse associationIndirect immunofluorescent antibodyFrequency of injectionsUrban transmission cyclesBartonella speciesBartonella organismsMode of transmissionCurrent natural historyImmunodeficiency syndrome
1995
Thrombocytopenia in pregnant women who use cocaine
Kain Z, Mayes L, Pakes J, Rosenbaum S, Schottenfeld R. Thrombocytopenia in pregnant women who use cocaine. American Journal Of Obstetrics And Gynecology 1995, 173: 885-890. PMID: 7573263, DOI: 10.1016/0002-9378(95)90360-7.Peer-Reviewed Original ResearchConceptsLow platelet countDrug-free groupPlatelet countCocaine groupHuman immunodeficiency virus statusCocaine-abusing parturientsRate of thrombocytopeniaIndependent risk factorAssociation of thrombocytopeniaCocaine-using groupIllicit drug useParturient populationSeropositive womenCohort studyPregnant womenDrug groupsPrenatal centersMedical recordsRisk factorsVirus statusMedical conditionsThrombocytopeniaIllicit drug usageNineteen subjectsOpiate group
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply